Published: 2020-05-22

Effects of probiotics on stool frequency in term newborns

Ashiana S., Gurmeet S.


Background: Probiotics are live micro-organisms, which if given in the right doses, can be beneficial to their host. They are known for their ability to promote the growth of other micro-organisms and to increase the activity of bacteria in the intestinal microflora. Supplementing infants with probiotics was shown to regulate gastrointestinal motility. They can stimulate intestinal peristalsis, which promotes elimination of bilirubin. Probiotics have been shown to increase intestinal transit time.

Methods: This study was conducted in Shri Guru Ram Das Institute of Health Sciences and Research involving 150 term healthy newborns. They were divided into two groups. Group 1 was given probiotics with 10ml distilled water and group 2 was given only 10ml distilled water from 1st to 3rd day of life. Total number of stools passed in a day were recorded from 1st to 7th day of life in both the groups.

Results: The mean frequency of stools were 3.76±1.08, 3.72±0.95, 4.02±0.92 in group 1 whereas the mean frequency of stools were 3.31±1.10, 3.39±0.98, 3.45±0.99 on 1st, 2nd, 3rd  day of life respectively.

Conclusions: Statistically significant increase in frequency of stools were observed in group 1(probiotic group) than group 2 (only distilled water group) on 1st to 3rd day of life.


Probiotics, Peristalsis, Stool

Full Text:



Gasbarrini G, Bonvicini F, Gramenzi A. Probiotics history. J Clinl Gastroenterol. 2016 Nov 1;50:S116-9.

Mutlu M, Irmak E, Aslan Y, Kader Ş. Effects of Lactobacillus rhamnosus GG as a probiotic on neonatal hyperbilirubinemia. Turkish J Pediatr. 2018 Sep 1;60(5):482-7.

Torkaman M, Mottaghizadeh F, Khosravi MH, Najafian B, Amirsalari S, Afsharpaiman S. The Effect of Probiotics on Reducing Hospitalization Duration in Infants with Hyperbilirubinemia. Iran J Pediatr. 2017;27(1):e57096.

Suganthi V, Das AG. Role of Saccharomyces boulardii in Reduction of Neonatal Hyperbilirubinemia. J Clin Diagn Res. 2016 Nov;10(11):SC12-15.

Liu W, Liu H, Wang T, Tang X. Therapeutic effects of probiotics on neonatal jaundice. Pak J Med Sci. 2015 Sep;31(5):1172-5.

Adoba P, Ephraim RK, Kontor KA, Bentsil JJ, Adu P, Anderson M, et al. Knowledge level and determinants of neonatal jaundice: a cross-sectional study in the effutu municipality of Ghana. Int J Pediatr. 2018;2018.

Bisceglia M, Indrio F, Riezzo G, Poerio V, Corapi U, Raimondi F. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Paediatrica. 2009 Oct;98(10):1579-81.

Ahmadipour S, Baharvand P, Rahmani P, Hasanvand A, Mohsenzadeh A. Effect of Synbiotic on the Treatment of Jaundice in Full Term Neonates: A Randomized Clinical Trial. Pediatr Gastroenterol, Hepatol Nutr. 2019 Sep 1;22(5):453-9.

Chen Z, Zhang L, Zeng L, Yang X, Jiang L, Gui G, et al. Probiotics supplementation therapy for pathological neonatal jaundice: a systematic review and meta-analysis. Front Pharmacol. 2017 Jun 30;8:432.

Armanian AM, Barekatain B, Hoseinzadeh M, Salehimehr N. Prebiotics for the management of hyperbilirubinemia in preterm neonates. J Matern Fetal Neonatal Med. 2016 Sep 16;29(18):3009-13.